This R21 application is in response to PA-03-171. Neonatal alloimmune thrombocytopenia (NATP), a significant cause of morbidity and mortality in newborn infants, is the result of maternal immunization against platelet-specific alloantigens inherited from the father. Early diagnosis and treatment (pre-natal or postnatal) of this condition can greatly improve the outcome. """"""""Common"""""""" platelet antigens known to induce antibodies that cause NATP can now be typed for and the corresponding antibodies can by detected reliably by referral laboratories. However, maternal immunization against these antigens can be documented only in about one-third of cases. We have obtained preliminary evidence that an important reason for the low diagnostic yield is that many mothers are immunized against """"""""private"""""""" (rare) platelet-specific alloantigens not previously reported or described only in single case reports. In this application, studies are proposed to facilitate early diagnosis of NATP and to enable improved pre-natal and post-natal management with these objectives: 1. Characterize the extent to which NATP is caused by maternal immunization against low frequency platelet-specific alloantigens by typing DNA from fathers of unresolved NATP cases for recognized """"""""rare"""""""" alloantigens. 2. Define the role of previously undescribed alloantigens as immunogens in NATP utilizing archived DNA samples from the same patient population. 3. Estimate the prevalence of """"""""rare"""""""" platelet-specific alloantigens in the normal population using high throughput, DNA-based screening methods. 4. Generate soluble recombinant platelet glycoproteins carrying """"""""rare"""""""" platelet alloantigens to provide a tool for rapid detection and identification of antibodies in mothers who are immunized against these antigens

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HL079085-01
Application #
6850977
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Mondoro, Traci
Project Start
2005-08-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
1
Fiscal Year
2005
Total Cost
$184,824
Indirect Cost
Name
Bloodcenter of Wisconsin, Inc.
Department
Type
DUNS #
057163172
City
Milwaukee
State
WI
Country
United States
Zip Code
53233
Peterson, Julie A; Gitter, Maria; Bougie, Daniel W et al. (2014) Low-frequency human platelet antigens as triggers for neonatal alloimmune thrombocytopenia. Transfusion 54:1286-93
Peterson, Julie A; McFarland, Janice G; Curtis, Brian R et al. (2013) Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol 161:3-14
Peterson, Julie A; Kanack, Adam; Nayak, Dhirendra et al. (2013) Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy. Transfusion 53:1309-18
Peterson, Julie A; Pechauer, Shannon M; Gitter, Maria L et al. (2012) The human platelet antigen-21bw is relatively common among Asians and is a potential trigger for neonatal alloimmune thrombocytopenia. Transfusion 52:915-6
Peterson, Julie A; Gitter, Maria L; Kanack, Adam et al. (2010) New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia. Transfusion 50:324-33